PUBLISHER: TechNavio | PRODUCT CODE: 1400389
PUBLISHER: TechNavio | PRODUCT CODE: 1400389
The bilirubin blood test market is forecasted to grow by USD 552.66 mn during 2023-2028, accelerating at a CAGR of 6.24% during the forecast period. The report on the bilirubin blood test market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of jaundice and liver diseases, technological advancements in bilirubin blood testing, and increasing incidence of preterm births.
Market Scope | |
---|---|
Base Year | 2023 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 5.75% |
CAGR | 6.24% |
Incremental Value | $552.66mn |
Technavio's bilirubin blood test market is segmented as below:
By End-user
By Product Type
By Geographical Landscape
This study identifies the increasing demand for non-invasive blood bilirubin procedures as one of the prime reasons driving the bilirubin blood test market growth during the next few years. Also, government initiatives and funding for bilirubin testing and rapid growth potential in emerging economies will lead to sizable demand in the market.
The report on the bilirubin blood test market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bilirubin blood test market vendors that include Abbott Laboratories, Advanced Instruments LLC, ALLMEDTECH, AMETEK Inc., Anamol Laboratories Pvt. Ltd., BIOGENIX Inc. Pvt. Ltd., DiaSys Diagnostic Systems GmbH, Dragerwerk AG and Co. KGaA, ELITechGroup SAS, F. Hoffmann La Roche Ltd., GINEVRI Srl, Jaiprakash Associates Ltd., Koninklijke Philips N.V., Mega Lab SA, Merck KGaA, Micro Lab Instruments, Randox Laboratories Ltd., Siemens AG, Teco Diagnostics, and Thermo Fisher Scientific Inc.. Also, the bilirubin blood test market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: